Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL).
Drachtman, Richard A
Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL). [electronic resource] - Leukemia & lymphoma 10 2016 - 2275-80 p. digital
Publication Type: Journal Article
1029-2403
10.3109/10428194.2016.1141406 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Child
Child, Preschool
Consolidation Chemotherapy
Female
Humans
Infant
Male
Methylenetetrahydrofolate Reductase (NADPH2)--genetics
Polymorphism, Genetic
Precursor Cell Lymphoblastic Leukemia-Lymphoma--diagnosis
Recurrence
Remission Induction
Testicular Neoplasms--secondary
Treatment Outcome
Young Adult
Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL). [electronic resource] - Leukemia & lymphoma 10 2016 - 2275-80 p. digital
Publication Type: Journal Article
1029-2403
10.3109/10428194.2016.1141406 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Child
Child, Preschool
Consolidation Chemotherapy
Female
Humans
Infant
Male
Methylenetetrahydrofolate Reductase (NADPH2)--genetics
Polymorphism, Genetic
Precursor Cell Lymphoblastic Leukemia-Lymphoma--diagnosis
Recurrence
Remission Induction
Testicular Neoplasms--secondary
Treatment Outcome
Young Adult